AAAAAA
Results: 1-25/46
Authors:
BLEIBERG H
Citation: H. Bleiberg, SHOULD THERE BE MASS-SCREENING USING FECAL OCCULT BLOOD-TESTS FOR COLORECTAL-CANCER - ARBITER, European journal of cancer, 34(6), 1998, pp. 778-780
Authors:
BLEIBERG H
DUCHATEAU J
MBON JBN
GERARD B
BRON D
DEBUSSCHER L
STRYCKMANS P
Citation: H. Bleiberg et al., INCREASED INCIDENCE OF LYMPHOMAS AND CARCINOMAS IN PATIENTS WITH CELIAC-DISEASE, European journal of cancer, 34(4), 1998, pp. 592-593
Authors:
BLEIBERG H
HULSTAERT F
BUYSE M
DEKEYSER P
Citation: H. Bleiberg et al., TROPISETRON IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING OVER 6 COURSES OF EMETOGENIC CHEMOTHERAPY, Anti-cancer drugs, 9(9), 1998, pp. 773-777
Authors:
GERARD B
BLEIBERG H
VANDAELE D
GIL T
HENDLISZ A
DILEO A
FERNEZ B
BRIENZA S
Citation: B. Gerard et al., OXALIPLATIN COMBINED TO 5-FLUOROURACIL AND FOLINIC ACID - AN EFFECTIVE THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Anti-cancer drugs, 9(4), 1998, pp. 301-305
Authors:
BLEIBERG H
Citation: H. Bleiberg, CONTINUING THE FIGHT AGAINST ADVANCED COLORECTAL-CANCER - NEW AND FUTURE TREATMENT OPTIONS, Anti-cancer drugs, 9(1), 1998, pp. 18-28
Authors:
GOEDHALS L
HERON JF
KLEISBAUER JP
PAGANI O
SESSA C
GIGER K
CAVALLI F
LUDWIG C
AAPRO M
BLEIBERG H
DEWASH G
DICATO M
TAGNON A
VANSTRAELEN D
VINDEVOGHEL A
ABRATT R
FALKSON G
BARLEY V
CARMICHAEL J
COLEMAN R
DAVIDSON N
GRIEVE R
HARPER P
ROBERTS J
RUSTIN G
NAMAN H
SCHNEIDER M
NOBLE A
NETTER P
CUPISSOL D
BALMES P
CALS L
KHAYAT D
CATIMEL G
DUTIN JP
BOUFETTE P
ADENIS L
MISSET J
COLLERY P
NOUVET G
CHAVAILLON JM
BLANCHON F
POIRIER R
ARNAUD A
LECAER H
CARLES P
MUIR J
BONNAUD F
MARQUESTE L
CLAVIER J
GUERIN J
TAYTARD A
KEIZER H
NORTIER J
SLEE P
WILS J
RODENBURG C
BURGHOUTS J
DEWIT R
GARCIAGIRON C
JIMENEZLACAVE A
CRUZHERNANDEZ J
MASSUTISUREDA B
HANS K
FUCHS R
KRIEGMAIR M
SCHULLER J
LAHOUSEN M
PANNUTI F
MONFARDINI S
NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
Authors:
BLEIBERG H
Citation: H. Bleiberg, REVIEW OF COLORECTAL (CRC) TRIALS IN EUROPE - DURABLE ACHIEVEMENTS FUTURE STUDIES, Annals of oncology, 9, 1998, pp. 7-7
Authors:
KERGER J
DEVALERIOLA D
BLEIBERG H
BARTHOLOMEUS S
BRASSINNE C
WYTHOUCK H
SOULAS F
CAZENAVE I
PICCART M
Citation: J. Kerger et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY OF THE COMBINATION OF DOCETAXEL (TXT), CISPLATIN (DDP) AND FLUOROURACIL (5-FU) IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 364-364
Authors:
GRIMALDI C
BLEIBERG H
GAY F
MESSNER M
ROUGIER P
KOK TC
CIRERA L
CERVANTES A
DEGREVE J
PAILLOT B
BUSET M
NITTI D
SAHMOUD T
DUEZ N
WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
Authors:
BLEIBERG H
SAHMOUD T
DILEO A
CUNNINGHAM D
ROUGIER P
Citation: H. Bleiberg et al., ADEQUATE NUMBER OF PATIENTS ARE NEEDED TO EVALUATE ADJUVANT TREATMENTIN GASTRIC-CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3714-3714
Authors:
BAKER J
BLEIBERG H
HUTCHISON G
JACKMAN A
KERR D
LABIANCA R
MACDONALD J
MEYER HJ
MINSKY B
NORDLINGER B
ROUGIER P
SMITS S
SOBRERO A
TAYLOR I
VERWEIJ J
Citation: J. Baker et al., AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997), Annales chirurgiae et gynaecologiae, 87(3), 1998, pp. 255-264
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Authors:
ROUGIER P
VANCUTSEM E
BAJETTA E
NIEDERLE N
POSSINGER K
LABIANCA R
NAVARRO M
MORANT R
BLEIBERG H
WILS J
AWAD L
HERAIT P
JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
Authors:
BLEIBERG H
DEGRAMONT A
Citation: H. Bleiberg et A. Degramont, OXALIPLATIN PLUS 5-FLUOROURACIL - CLINICAL-EXPERIENCE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Seminars in oncology, 25(2), 1998, pp. 32-39
Authors:
BLEIBERG H
Citation: H. Bleiberg, EDRECOLOMAB (MONOCLONAL-ANTIBODY 17-1A) - A VIEWPOINT BY BLEIBERG,HARRY, Drugs, 56(4), 1998, pp. 627-627
Authors:
BLEIBERG H
Citation: H. Bleiberg, OXALIPLATIN (L-OHP) - A NEW REALITY IN COLORECTAL-CANCER, British Journal of Cancer, 77, 1998, pp. 1-3
Authors:
BLEIBERG H
CONROY T
PAILLOT B
LACAVE AJ
BLIJHAM G
JACOB JH
BEDENNE L
NAMER M
DEBESI P
GAY F
COLLETTE L
SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
Authors:
BLEIBERG H
Citation: H. Bleiberg, NEW DRUGS AND THEIR POSSIBLE IMPACT ON PATIENT OUTCOME, European journal of cancer, 33, 1997, pp. 1293-1293
Authors:
BLEIBERG H
Citation: H. Bleiberg, SHOULD PATIENTS WITH ADVANCED COLORECTAL-CANCER BE TREATED WITH CHEMOTHERAPY - ARBITER, European journal of cancer, 33(6), 1997, pp. 822-824
Authors:
BLEIBERG H
Citation: H. Bleiberg, COLORECTAL-CANCER - IS THERE AN ALTERNATIVE TO 5-FU, European journal of cancer, 33(4), 1997, pp. 536-541
Authors:
BLEIBERG H
GERARD B
WILS J
BLIJHAM G
DIAZRUBIO E
HERRMANN R
KERR D
LABIANCA R
ROUGIER P
WILKE HJ
WILKING N
Citation: H. Bleiberg et al., GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE, European journal of cancer, 33(10), 1997, pp. 1536-1545
Authors:
BLEIBERG H
GERARD B
HENDLISZ A
JAGODZINSKI R
Citation: H. Bleiberg et al., NONSURGICAL TREATMENT OF CANCER OF THE PANCREAS, Journal de chirurgie, 134(4), 1997, pp. 169-173
Authors:
BLEIBERG H
JEZIORSKY K
HENDLISZ A
GERARD B
Citation: H. Bleiberg et al., IMPORTANCE OF RADIOTHERAPY FOR GASTRIC-CANCER, Bulletin du cancer, 84(9), 1997, pp. 913-916
Authors:
PUNT CJA
VOEST EE
TUENI E
VANOOSTEROM AT
BACKX A
DEMULDER PHM
HECQUET B
LUCAS C
GERARD B
BLEIBERG H
Citation: Cja. Punt et al., PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER, British Journal of Cancer, 76(10), 1997, pp. 1376-1381
Authors:
ROUGIER P
VANPOTTELSBERGHE C
KOK T
PAILLOT B
WAGENER T
DEGREVE J
FABRI MC
GERARD B
VANGLABBEKE M
BLEIBERG H
Citation: P. Rougier et al., FOTEMUSTINE IN PATIENTS WITH ADVANCED GASTRIC-CANCER, A PHASE-II TRIAL FROM THE EORTC-GITCCG (EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP), European journal of cancer, 32A(8), 1996, pp. 1432-1433